Abstract
We are now witnessing the rise of a new era of research in toxicology which Zbinden has called the “era of individual expression” (Zbinden, 1992). It has been recognized that inherited genetic differences determine the susceptibility of an individual to a toxic chemical. Most of the specific factors described so far refer to the metabolism of xenobitocs which is critical for the balance of toxification and detoxification.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agarwal DP, Goedde HW (1992) Pharmacogenetics of alcohol metabolism and alcoholism. Pharmacogenetics 2: 48–62
Bell DA (1994) Ethnic variation in xenobiotic metabolism and increased risk for carcinogen-induced bladder cancer. ISSX Proceedings 6: 51
Bogaards JJP, van Immen B, van Bladeren PJ (1993) Interindividual differences in the in vitro conjugation of methylene chloride with glutathione S-transferase in 22 human liver samples. Biochem Pharmacol 45: 2166–2169
Bogaards JJP, van Immen B, van Bladeren PJ (1993) Interindividual differences in the in vitro conjugation of methylene chloride with glutathione S-transferase in 22 human liver samples. Biochem Pharmacol 45: 2166–2169
Bolt HM, Gansewendt, B (1994) Mechanism of carcinogenicity of methyl halides. CRC Crit Rev Toxicol 23: 237–253
Brian WR, Sari MA, Iwasaki M (1990) Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccaromyces cerevisiae. Biochemistry 29: 11280–11292
Butler MA, Lang NP, Young IF et al. (1992) Determination of CYP1A2 and N- acetyltransferase 2 phenotypes in human population by analysis of caffeine urinary metabolites. Pharmacogenetics 2: 116–127
Caporaso N, Landi MT, Vineis P (1991) Relevance of metabolic polymorphisms to human carcinogenesis; evaluation of epidemiologic evidence. Pharmacogenetics 1: 4–19
Caporaso N, De Baum MR, Rothman N (1995) Lung cancer and CYP 2D6 (the debrisoquine polymorphism): sources of heterogenicity in the proposed association. Pharmacogenetics 5, Suppl.: S129–S134
Dahl ML, Bertilsson L (1993) Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics 3: 61–70
Deguchi T, Mashimo M, Suzuki T (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J Biol Chem 265: 12757–12760
Deutsche Forschungsgemeinschaft (1994) Maximum concentrations at the workplace and biological tolerance values for working materials. VCH Publ., Weinheim
Deutsche Forschungsgemeinschaft (1993) Biologische Arbeitsstoff-Toleranzwerte (BAT- Werte). Arbeitsmedizinisch-Toxikologische Begriindungen. 7. Lfg., Henschler D, Lehnert G (eds). VCH Verl.Ges., Weinheim
Grant DM (1993) Molecular genetics of aromatic amines. Pharmacogenetics 3: 45–50
Goldzieher JW, Dozier TS, de la Pena A (1980) Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. Contraception 21: 1–15
Hanke J, Kajewska A (1990) Acetylation phenotype and bladder cancer. J Occup Med 32: 917–918
Hayes RB, Rothman N, Broly F et al. (1993) N-Acetylation phenotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14: 675–678
Idle JR, Armstrong M, Boddy AV et al. (1992) The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics 2: 246–258
Kalow W, Staron N (1957) On the distribution and inheritance of a typical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem 35: 1305
Kalow W, Staron N (1957) On the distribution and inheritance of a typical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem 35: 1305
Kerlau V, Dreano Y, Bercovici JP (1992) Nature of cytochromes P-450 involved in the 2/4-hydroxylations of estradiol in human liver microsomes. Biochem Pharmacol 44: 1745–1756
Laib RJ, Tucholski M, Filser JG, Csanady GA (1992) Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats. Arch Toxicol 66: 310–314
Lewalter J, Miksche LW (1991) Empfehlungen zur arbeitsmedizinischen Prevention expositions- und dispositionsbedingter Arbeitsstoff-Beanspruchungen. Verh Dt Ges Arbeitsmed 31: 135–139
Löhr GW (1970) Uber die Bedeutung genetisch bedingter Enzymdefekte fur die Pharmakotherapie. In: Lohr GW, Blum KU, Wiedemann OJ (eds) Enzyme und Pharmaka. Editiones “Roche”, Grenzach, pp 79–101
Nebert DW, Adesnik M, Coon MJ, et al. (1987) The P-450 gene superfamily: recommended nomenclature. DNA 6: 1–11
Rancy JL, Kraner JC, Lasker JM (1993). Bioactivation of halogenated hydrocarbons by cytochrome P-450E1. CRC Crit Rev Toxicol 23: 1–20
Rancy JL, Kraner JC, Lasker JM (1993). Bioactivation of halogenated hydrocarbons by cytochrome P-450E1. CRC Crit Rev Toxicol 23: 1–20
Sugimura H, Hamada GS, Suzuki J, Iwase T, Kiyokawa E, Kini J, Tsugane S (1995) CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brasil. Pharmacogenetics 5, Suppl.: S145–S148
Vesell ES (1975) Pharmacogenetics. Biochem Pharmacol 24: 445–450
Weber WW, Hein DW, Litwin A, Lower GM (1983) Relationship of acetylator status to isonioazid toxicity, lupus erythematosus and bladder cancer. FASEB J 42: 3086–3097
Yoshida A (1992) Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics 2: 139–147
Zbinden G (1992) The three eras of research in experimental toxicology. TIPS 13: 221–223
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bolt, H.M. (1996). Genetic Predisposition in Occupational Toxicology. In: Seiler, J.P., Kroftová, O., Eybl, V. (eds) Toxicology - From Cells to Man. Archives of Toxicology, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61105-6_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-61105-6_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64696-6
Online ISBN: 978-3-642-61105-6
eBook Packages: Springer Book Archive